Cargando…
Modifiable Lifestyle and Medical Risk Factors Associated With Myeloproliferative Neoplasms
Despite the identification of acquired genetic mutations associated with Myeloproliferative Neoplasms (MPNs) there is a paucity of information relating to modifiable risk factors that may lead to these mutations. The MOSAICC Study was an exploratory case-control study of polycythemia vera (PV), esse...
Autores principales: | Duncombe, Andrew S., Anderson, Lesley A., James, Glen, de Vocht, Frank, Fritschi, Lin, Mesa, Ruben, Clarke, Mike, McMullin, Mary Frances |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000482/ https://www.ncbi.nlm.nih.gov/pubmed/32072143 http://dx.doi.org/10.1097/HS9.0000000000000327 |
Ejemplares similares
-
Patient perspectives of a diagnosis of myeloproliferative neoplasm in a case control study
por: McMullin, Mary Frances, et al.
Publicado: (2016) -
Aetiology of Myeloproliferative Neoplasms
por: McMullin, Mary Frances, et al.
Publicado: (2020) -
The JAK2(V617F)
mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden
por: Orbell, Lai Yee, et al.
Publicado: (2023) -
Epigenetics in myeloproliferative neoplasms
por: Greenfield, Graeme, et al.
Publicado: (2023) -
Epigenetics in Myeloproliferative Neoplasms
por: McPherson, Suzanne, et al.
Publicado: (2017)